Literature DB >> 25850806

Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis.

Carina Dexter1, Gerald L Murray, Ian T Paulsen, Anton Y Peleg.   

Abstract

Community-acquired Acinetobacter baumannii (CA-Ab) is a rare but serious cause of community-acquired pneumonia in tropical regions of the world. CA-Ab infections predominantly affect individuals with risk factors, which include excess alcohol consumption, diabetes mellitus, smoking and chronic lung disease. CA-Ab pneumonia presents as a surprisingly fulminant course and is characterized by a rapid onset of fever, severe respiratory symptoms and multi-organ dysfunction, with a mortality rate reported as high as 64%. It is unclear whether the distinct clinical syndrome caused by CA-Ab is because of host predisposing factors or unique bacterial characteristics, or a combination of both. Deepening our understanding of the drivers of overwhelming CA-Ab infection will provide important insights into preventative and therapeutic strategies.

Entities:  

Keywords:  A. baumannii; CA-Ab; community-acquired pneumonia; ethanol

Mesh:

Year:  2015        PMID: 25850806     DOI: 10.1586/14787210.2015.1025055

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  45 in total

Review 1.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

2.  Characterization and distribution of drug resistance associated β-lactamase, membrane porin and efflux pump genes in MDR A. baumannii isolated from Zhenjiang, China.

Authors:  Huijian Yang; Lan Huang; Prince Amoah Barnie; Zhaoliang Su; Zuhuang Mi; Jianguo Chen; Vasudevan Aparna; Dinesh Kumar; Huaxi Xu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Molecular Characterization and Antibiotic Susceptibility Profile of Acinetobacter baumannii Recovered from Hospital Wastewater Effluents.

Authors:  Qaqamba Mapipa; Tennison Onoriode Digban; Nonso Emmanuel Nnolim; Nolonwabo Nontongana; Anthony Ifeanyi Okoh; Uchechukwu U Nwodo
Journal:  Curr Microbiol       Date:  2022-03-08       Impact factor: 2.188

4.  Genomic Characterization of Mobile Genetic Elements Associated With Carbapenem Resistance of Acinetobacter baumannii From India.

Authors:  Saranya Vijayakumar; Jobin John Jacob; Karthick Vasudevan; Purva Mathur; Pallab Ray; Ayyanraj Neeravi; Ashtawarthani Baskaran; Agilandeeswari Kirubananthan; Shalini Anandan; Indranil Biswas; Kamini Walia; Balaji Veeraraghavan
Journal:  Front Microbiol       Date:  2022-06-15       Impact factor: 6.064

Review 5.  Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?

Authors:  Samuel Kariuki; Kelvin Kering; Celestine Wairimu; Robert Onsare; Cecilia Mbae
Journal:  Infect Drug Resist       Date:  2022-07-07       Impact factor: 4.177

6.  InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis.

Authors:  Clay D Jackson-Litteken; Gisela Di Venanzio; Nguyen-Hung Le; Nichollas E Scott; Bardya Djahanschiri; Jesus S Distel; Evan J Pardue; Ingo Ebersberger; Mario F Feldman
Journal:  mBio       Date:  2022-05-31       Impact factor: 7.786

7.  The influence of bacterial interaction on the virulence of Cryptococcus neoformans.

Authors:  Sanjiveeni Dhamgaye; Gerald L Murray; Anton Y Peleg
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 8.  Uncovering the mechanisms of Acinetobacter baumannii virulence.

Authors:  Christian M Harding; Seth W Hennon; Mario F Feldman
Journal:  Nat Rev Microbiol       Date:  2017-12-18       Impact factor: 60.633

9.  Caspase-11 Plays a Protective Role in Pulmonary Acinetobacter baumannii Infection.

Authors:  Wei Wang; Yue Shao; Shengjun Li; Na Xin; Tingxian Ma; Chenghai Zhao; Min Song
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

10.  Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR Acinetobacter baumannii: In silico, in vitro and in vivo Studies.

Authors:  Afreenish Hassan; Aamer Ikram; Abida Raza; Sidra Saeed; Rehan Zafar Paracha; Zumara Younas; Muhammad Tahir Khadim
Journal:  Int J Nanomedicine       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.